Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Price Ron

2. Date of Event Requiring Statement (MM/DD/YYYY) 3/7/2017

3. Issuer Name and Ticker or Trading Symbol

Accelerate Diagnostics, Inc [AXDX]

(Last) (First) (Middle)

C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB RD., SUITE 470

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
SVP & HEAD OF COM OPS AMERICAS /

(Street)

TUCSON, AZ 85714

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	⁽¹⁾	5/27/2025	Common Stock	100000	$22.66	D
Employee Stock Option (right to buy)	2/17/2017	2/17/2026	Common Stock	2749	$11.52	D
Employee Stock Option (right to buy)	⁽²⁾	3/17/2026	Common Stock	30000	$12.42	D
Employee Stock Option (right to buy)	⁽³⁾	2/23/2027	Common Stock	7836	$24.45	D
Employee Stock Option (right to buy)	⁽⁴⁾	2/23/2027	Common Stock	25000	$24.45	D

Explanation of Responses:
( 1)	40% of the options vest on May 27, 2017, and the balance vests in 36 equal monthly installments beginning on June 27, 2017.
( 2)	The option vests in five equal annual installments beginning on March 17, 2017.
( 3)	The option vests in 12 equal monthly installments beginning on February 23, 2018.
( 4)	The option vests in five equal annual installments beginning on February 23, 2018.

Remarks:
Exhibit List: Exhibit 24 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Price Ron C/O ACCELERATE DIAGNOSTICS, INC. 3950 S. COUNTRY CLUB RD., SUITE 470 TUCSON, AZ 85714			SVP & HEAD OF COM OPS AMERICAS

Signatures
/s/ David Hinnant, attorney-in-fact		3/15/2017
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.